Data analytics firm Diaceutics PLC (LON:DXRX) made a bright start to its life on AIM with the shares shooting higher in first deals.
Placed at 76p, the shares were trading at 87.5p in first dealings valuing the group at about £61mln.
WATCH: Diaceutics PLC makes strong start on London's AIM debut
The Belfast-based group serves the global pharmaceutical industry and collects laboratory, anonymised patient, and insurance claims data, which it then uses to develop diagnostic testing strategies for its clients.
It currently has data sets from over 2,500 labs including 3.5mln patient records.
Diaceutics raised £17mln in new money ahead of the listing with £3mln of the funds earmarked to develop NEXUS, its software-as-a-service (SaaS) platform.
Existing shareholders also sold £3.75mln worth of equity ahead of the float.